IBM Study: CEOs Double Down on AI While Navigating Enterprise Hurdles

Go back to IBM Study: CEOs Double Down on AI While Navigating Enterprise Hurdles

Morgan Stanley Reiterates Equalweight Rating on IBM (IBM)

May 7, 2025 6:30 AM EDT

Morgan Stanley analyst Erik Woodring reiterated an Equalweight rating and $233.00 price target on IBM (NYSE: IBM)

The analyst comments "IBM Think 2025 - The Year of Agentic AI. IDC estimates that 1B new applications will be created by 2028 due to GenAI innovations, with these apps leveraging... More